Image

Global Live Cell Imaging Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Jun 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Live Cell Imaging Market, By Product and Service (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Developmental Biology, Drug Discovery), End-Users (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations), Technology (Time Lapse Microscopy, Fluorescence Recovery After Photo Bleaching, High Content Screening, Fluorescence Resonance Energy Transfer, Others) – Industry Trends and Forecast to 2029

Live Cell Imaging Market

Market Analysis and Size

The live cell imaging market is expected to expand, during the forecast period. Live cell imaging is a technique that allows scientists to investigate cells, their structures, functions, and properties in real time. The approach has revolutionised research into molecular interactions, cells, proteins, and a wide range of activities. Because live cell imaging is less susceptible to experimental artefacts than fixed cell imaging, the market for live cell imaging has a solid platform on which to build.

Data Bridge Market Research analyses that the live cell imaging market which was USD 3.41 billion in 2021, would rocket up to USD 6.21 billion by 2029, and is expected to undergo a CAGR of 7.78% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product and Service (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Developmental Biology, Drug Discovery), End- Users (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations), Technology (Time Lapse Microscopy, Fluorescence Recovery After Photo Bleaching, High Content Screening, Fluorescence Resonance Energy Transfer, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Bio-Rad Laboratories, Inc. (U.S), Agilent Technologies (U.S), Cytiva (U.S), Blue-Ray Biotech Corp. (Taiwan), CytoSMART Technologies (Netherlands), Curiosis Inc. (South Korea), Carl Zeiss AG (U.S), General Electric (U.S), Leica Microsystems (Germany), Thermo Fisher Scientific Inc. (U.S), Perkin Elmer (U.S), Danaher (U.S), Bruker (U.S), Nikon Corporation (Japan), and Olympus Corporation (Japan)

Market Opportunities

  • Adoption of high-content screening methods for primary screening
  • Use of live cell imaging in personalised medicine

Market Definition

The study of cells in real time using pictures obtained from screening devices and microscopes is known as live cell imaging. Scientists' approaches to studying proteins, molecular interactions, and internal structures of cells, as well as cellular processes and biological activities, have changed as a result of technological advancements. Instead of reviewing the photos of fixed cells, they can watch cells to acquire a more in-depth insight.

Live Cell Imaging Market Dynamics

Drivers

  • Increasing research and development activities

Increasing research and development investment is likely to boost market growth. Other factors such as rising cancer incidence, rising adoption of high-content screening approaches in drug discovery, increasing demand for better and faster diagnostic facilities, and technological advancement are likely to propel the live cell imaging market forward from 2022 to 2029.

  • Approval of high-content screening techniques

The adoption of high-content screening techniques, large government funding for cell-based research, and rising cancer occurrences worldwide are driving the global live cell imaging market. Market players can benefit from the adoption of high-content screening methods for primary screening and the use of live cell imaging in personalised medicine.

  • Advancement Technologies

According to a poll conducted by Drug Discovery World Spring, nearly 21% of researchers favour and employ live cell imaging, with 31% planning to do so in the future. Furthermore, 38% of respondents said they would like to use live cell kinetic HCS imaging in the future. The capacity to automate the incubation and picture capture of any live cell analyser is the most significant feature for researchers. Second, they place a premium on the equipment's ability to track live cells. Over the projected period, more advancements in equipment technology are likely to meet these criteria and increase their utility.

Opportunities

The UK and Europe will face a major lack of lab skills over the next decade, according to Healthcare-in-Europe.com, an online platform that delivers trends in medical technology, new procedures, and breakthroughs in medical research. Medical laboratories will be among the most affected. Furthermore, according to the Gatsby Foundation's analysis, the UK will require an additional 700,000 technicians to sustain the economy by the end of 2030. As a result, in the next years, a scarcity of experienced workers is projected to stifle market expansion.

Restraints/Challenges

High cost of the high-content screening systems and lack of skilled and trained professionals is expected to hinder the market growth in the forecast period of 2022 to 2029.

This live cell imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the live cell imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 impact on Live Cell Imaging Market

COVID-19 has no effective treatment in the form of vaccinations or antiviral medicines at this time, hence patients are treated symptomatically. According to the WHO, 70 vaccine candidates are now being developed, with three of them already being tested in human trials. Many experts throughout the world are studying SARS-CoV-2, the virus that causes COVID-19, at the forefront of the COVID-19 outbreak. Researchers can use live cell imaging tools, such as sophisticated microscopy equipment, to analyse cellular behaviour during viral research. To generate vaccines, biomedical research necessitates the processing of massive amounts of data. As a result, prominent live cell imaging system vendors including Leica Microsystems in Germany and CytoSMART Technologies in the Netherlands have contributed live cell imaging systems to COVID-19 researchers.

Recent Development

  • In December 2020, Horizon Discovery was purchased for an unknown sum by PerkinElmer Inc., a US-based diagnostics company with detection, imaging, informatics, and service capabilities.

Global Live Cell Imaging Market Scope

The live cell imaging market is segmented on the basis of product, application and technology. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Equipment
  • Consumable
  • Software

Application

  • Cell Biology
  • Developmental Biology
  • Stem Cell and Drug Discovery
  • Others

Technology

  • Time-lapse Microscopy
  • Fluorescence recovery after photobleaching (FRAP)
  • Fluorescence resonance energy transfer (FRET)
  • High content screening (HCS)
  • Others

Live Cell Imaging Market Regional Analysis/Insights

The live cell imaging market is analysed and market size insights and trends are provided by country, product, application and technology as referenced above.

The countries covered in the live cell imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominated due to its high investment rate and technologically sound infrastructure. The research firms present in this region are technologically aware, hence, readily invest in high-cost equipment.

Asia-Pacific is expected to show the fastest growth over the forecast period due to the growing application of these imaging techniques in drug discovery and personalized medicine.

 The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Live Cell Imaging Market Share Analysis

The live cell imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to live cell imaging market.

Some of the major players operating in the live cell imaging market are:

  • Bio-Rad Laboratories, Inc. (U.S)
  • Agilent Technologies (U.S)
  • Cytiva (U.S)
  • Blue-Ray Biotech Corp. (Taiwan)
  • CytoSMART Technologies (Netherlands)
  • Curiosis Inc. (South Korea)
  • Carl Zeiss AG (U.S)
  • General Electric (U.S)
  • Leica Microsystems (Germany)
  • Thermo Fisher Scientific Inc. (U.S)
  • Perkin Elmer (U.S)
  •  Danaher (U.S)
  • Bruker (U.S)
  • Nikon Corporation (Japan)
  • Olympus Corporation (Japan)

Research Methodology: Global Live Cell Imaging Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The live cell imaging market value is expected USD 6.21 billion by 2029.
The Live Cell Imaging Market is to grow at a CAGR of 7.78% during the forecast by 2029.
On the basis of technology, the Live Cell Imaging Market is segmented into Time Lapse Microscopy, Fluorescence Recovery After Photo Bleaching, High Content Screening, Fluorescence Resonance Energy Transfer, Others.
On the basis of application, the Live Cell Imaging Market is segmented into Cell Biology, Stem Cells, Developmental Biology, Drug Discovery.